Swedbank Robur Medica
- Namn
- Swedbank Robur Medica
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- 2020-03-31
- Fondförmögenhet
- 8 968 421 455 SEK
- Likvida medel
- 436 845 615 SEK
- Övriga tillgångar och skulder
- 37 093 740 SEK
- Antal innehav
- 70
- Aktiv risk
- 3,23
- Standardavvikelse 24 månader
- 15,23
- Jämförelseindex
- MSCI World Health Care 10/40 Net
- Förvaltningsavgift
- 1,25% Fast
Största innehav
| Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
|---|---|---|---|
| United Health | 582 316 555 SEK | 6,49% | Health Care |
| Roche | 562 931 621 SEK | 6,28% | Health Care |
| Sanofi | 393 899 411 SEK | 4,39% | Health Care |
| Abbott Laboratories | 364 674 216 SEK | 4,07% | Health Care |
| Eli Lilly | 338 367 377 SEK | 3,77% | Health Care |
| Alexion Pharmaceuticals | 333 395 447 SEK | 3,72% | Health Care |
| Novo Nordisk | 316 124 929 SEK | 3,52% | Health Care |
| Thermo Fisher Scientific | 309 867 651 SEK | 3,46% | Health Care |
| Takeda Pharmaceutical | 289 679 070 SEK | 3,23% | Health Care |
| Centene | 276 347 857 SEK | 3,08% | Health Care |
| AstraZeneca | 275 015 458 SEK | 3,07% | Health Care |
| Merck | 259 585 654 SEK | 2,89% | Health Care |
| Bayer | 257 603 354 SEK | 2,87% | Health Care |
| Vertex Pharmaceuticals | 239 309 435 SEK | 2,67% | Health Care |
| Mylan | 180 631 244 SEK | 2,01% | Health Care |
| Edward Lifesciences | 175 492 793 SEK | 1,96% | Health Care |
| Horizon Therapeutics | 168 250 806 SEK | 1,88% | Health Care |
| Livanova | 163 931 417 SEK | 1,83% | Health Care |
| Swedish Orphan Biovitrum | 152 820 000 SEK | 1,70% | Health Care |
| Hologic | 148 856 074 SEK | 1,66% | Health Care |
| Intuitive Surgical | 143 956 247 SEK | 1,61% | Health Care |
| IQVIA | 139 048 396 SEK | 1,55% | Health Care |
| Exelixis | 137 983 391 SEK | 1,54% | Health Care |
| Eisai | 128 613 278 SEK | 1,43% | Health Care |
| Ionis Pharmaceuticals | 116 872 616 SEK | 1,30% | Health Care |
Branscher
Källa: Finansinspektionen.